Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Myanmar Political Observer.
Press releases published on August 6, 2025
Jeremy Fields of Newsmatics Joins Forbes Communications Council
EIN Presswire
·
August 6, 2025
WASHINGTON , DC, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- Jeremy Fields, vice president of corporate development at Newsmatics, has been accepted into the Forbes Communications Council, a prestigious, invitation-only organization made up of …
SPACEMOBILE (ASTS) ALERT: Bragar Eagel & Squire, P.C. is Investigating AST SpaceMobile, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
August 6, 2025
Bragar Eagel …
Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug - Hagens Berman
GlobeNewswire
·
August 6, 2025
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), has been filed and seeks to represent investors who purchased or otherwise acquired Replimune ( …
EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. is Investigating Expensify, Inc. on Behalf of Expensify Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
August 6, 2025
Bragar Eagel …
NUTEX (NUTX) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutex Health Inc. on Behalf of Nutex Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
August 6, 2025
Bragar Eagel …
Centene Corporation (CNC) Shares Fall ~10% Pre-Market After Reporting Q2 2025 Diluted Loss Per Share, Class Action Lawsuit Over “Inflated Guidance” Pending – Hagens Berman
GlobeNewswire
·
August 6, 2025
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Before the markets opened on July 25, 2025, investors in Centene Corporation (NYSE: CNC) saw the price of their shares decline about 10% in pre-market trading after the company reported disastrous Q2 2025 …
FISERV (FI) ALERT: Bragar Eagel & Squire, P.C. is Investigating Fiserv, Inc. on Behalf of Fiserv Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
August 6, 2025
Bragar Eagel …
SMUCKER ALERT: Bragar Eagel & Squire, P.C. is Investigating J.M. Smucker Company on Behalf of Smucker Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
August 6, 2025
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
BARNES & NOBLE (BNED) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Barnes & Noble Education, Inc. on Behalf of Barnes & Noble Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
August 6, 2025
Bragar Eagel …
ENCOMPASS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Continuing Investigating Encompass Health Corporation on Behalf of Encompass Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
August 6, 2025
Bragar Eagel …
BELLRING BRANDS (BRBR) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of BellRing Brands Inc. Investors
GlobeNewswire
·
August 6, 2025
Bragar Eagel …
KBR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of KBR, Inc. Investors and Encourages Investors to Contact The Firm
GlobeNewswire
·
August 6, 2025
Bragar Eagel …
GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
August 6, 2025
Bragar Eagel …
EAGLE BANCORP ALERT: Bragar Eagel & Squire, P.C. is Investigating Eagle Bancorp, Inc. on Behalf of Eagle Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
August 6, 2025
Bragar Eagel …
Sable Offshore Corp. (SOC) Hit with Lawsuit Over Alleged Misleading Statements on California Oil Restart – Hagens Berman
GlobeNewswire
·
August 6, 2025
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sable Offshore Corp. (NYSE: SOC) is now at the center of a securities class-action lawsuit, alleging that the company misled investors to inflate its stock price just before a major secondary offering. The …
ROSEN, LEADING INVESTOR COUNSEL, Encourages Neogen Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NEOG
GlobeNewswire
·
August 6, 2025
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”), of the …
PEPG DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages PepGen Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 8 Deadline in Securities Class Action – PEPG
GlobeNewswire
·
August 6, 2025
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”), of the …
Lockheed Martin (LMT) Faces Investor Scrutiny Over Company’s Disclosures About Aeronautics and RMS Segments’ Performance, Securities Class Action Pending -- Hagens Berman
GlobeNewswire
·
August 6, 2025
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Khan v. Lockheed Martin Corporation, et al., No. 1:25-cv-06197 (S.D.N.Y.) has been filed and seeks to represent investors who purchased or otherwise acquired Lockheed …
BHVN INVESTORS: Kirby McInerney LLP Reminds Biohaven Ltd. Investors of Important Deadline and Encourages Investors to Contact the Firm
GlobeNewswire
·
August 6, 2025
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Connecticut on behalf of those who acquired Biohaven Ltd. (“Biohaven …
Sarepta Therapeutics (SRPT) Declines Again On EMA Recommendation to Refuse ELEVIDYS Marketing Authorization, Securities Class Action Pending – Hagens Berman
GlobeNewswire
·
August 6, 2025
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- On July 24, 2025, the European Medicines Agency (“EMA”) recommended the refusal of the marketing authorization for ELEVIDYS, Sarepta’s medication intended for the treatment of Duchenne muscular dystrophy. …